ELSN — Eleison Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual balance sheet for Eleison Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Cash and Short Term Investments | 0.054 | 4.87 | 1.09 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 0 | 1 | 0 |
| Prepaid Expenses | |||
| Total Current Assets | 0.06 | 5.87 | 1.09 |
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 0.061 | 5.87 | 1.39 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 13.4 | 3.62 | 1.37 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 13.4 | 4.12 | 1.88 |
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -13.3 | 1.76 | -0.484 |
| Total Liabilities & Shareholders' Equity | 0.061 | 5.87 | 1.39 |
| Total Common Shares Outstanding |